
This means that abarelix will cause birth defects in an unborn baby. Do not use this medication if you are pregnant or if you could become pregnant during treatment. You may not be able to use abarelix, or you may require a dosage adjustment or special monitoring during treatment. Abarelix is not intended for use by women. Abarelix is in the FDA pregnancy category X. This means that abarelix will cause birth defects in an unborn baby. Do not use this medication if you are pregnant or if you could become pregnant during treatment. Abarelix is not intended for use by women. It is not known whether abarelix passes into breast milk. Do not use this medication without first talking to your doctor if you are breast-feeding a baby. How should I use abarelix? Abarelix must be administered by a qualified healthcare provider. Abarelix is administered as an injection into the muscle. In some cases, the use of abarelix has resulted in serious allergic reactions. An allergic reaction may occur after any injection of the medication, including, but not limited to the first dose. Patients should be observed in the doctor's office for at least 30 minutes following each dose so that immediate treatment of an allergic reaction can be obtained if needed. Treatment with abarelix may become less effective over time in some patients. Monitoring blood levels of testosterone will be done on a regular basis with blood tests to monitor the effectiveness of the medication. It is important to use abarelix regularly to get the most benefit. Abarelix vials for injection should be stored at room temperature away from moisture and heat.
abarelix
luteinizing hormone
follicle stimulating hormone
gonadotropin releasing hormone
testosterone
estradiol
prolactin
progesterone
chorionic gonadotropin
androstenedione
gonadotropins, pituitary
androgens
estrogens
growth hormone
thyrotropin
hydrocortisone
gonadotropins
thyrotropin releasing hormone
hormones
gonadal steroid hormones
inhibins
dihydrotestosterone
rna, messenger
delayed action preparations
leuprolide
triptorelin
dehydroepiandrosterone
hormone antagonists
cetrorelix
adrenocorticotropic hormone
dehydroepiandrosterone sulfate
oligopeptides
clomiphene
antineoplastic agents, hormonal
insulin
buserelin
receptors, lhrh
recombinant proteins
gonadorelin
estrone
receptors, cell surface
hydroxyprogesterones
17 alpha hydroxyprogesterone
menotropins
thyroxine
antineoplastic agents
androgen antagonists
No comments:
Post a Comment